Use of serum CA-125 in monitoring patients with uterine sarcoma. A preliminary report.
Elevated preoperative serum CA-125 levels were present in three of four patients (75%) with Stage I uterine sarcoma found to have extrauterine spread of disease at laparotomy as well as five of seven (71%) patients with clinically advanced and recurrent uterine sarcoma. Serial levels during chemotherapy inconsistently reflected response to treatment and proved to have limited clinical value.